Novel approaches toward understanding the evolution of disease can lead to the discovery
of biomarkers that will enable better management of disease progression and improve …

Circulating tumor cells (CTCs) are a major contributor of cancer metastases and hold a
promising prognostic significance in cancer detection. Performing functional and molecular …

Biomimetic cell‐membrane‐camouflaged nanoparticles with desirable features have been
widely used for various biomedical applications. However, the current research focuses on …

Circulating tumor cells (CTCs) originate from the primary tumor mass and enter into the
peripheral bloodstream. Compared to other “liquid biopsy” portfolios such as exosome …

Small cell lung cancer (SCLC) patient-derived xenografts (PDX) can be generated from
biopsies or circulating tumor cells (CTC), though scarcity of tissue and low efficiency of tumor …

Carbon quantum dots (CQDs) have emerged as potential alternatives to classical metal-
based semiconductor quantum dots (QDs) due to the abundance of their precursors, their …

Isolation of metastatic circulating tumor cells (CTCs) from cancer patients is of high value for
disease monitoring and molecular characterization. Despite the development of many new …

Micro/nanomotors distinguish themselves with in situ energy conversion capability for
autonomous movement, a feature that confers remarkable potential to improve cancer …

Lung cancer affects over 1. 8 million people worldwide and is the leading cause of cancer
related mortality globally. Currently, diagnosis of lung cancer involves a combination of …

The field of cancer diagnostics has recently been impacted by new and exciting
developments in the area of liquid biopsy. A liquid biopsy is a minimally invasive alternative …